Delivery Order SPE2DB22D2006-SPE2DB24FV9FH
Award Date 4/2/24
Potential Completion Date 4/3/24
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with a ceiling value of $1,547.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. This is a firm fixed price delivery order contract with an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,287.65, is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical supply. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order with a ceiling value of $3,274.86 for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,562.24 firm-fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The $9,750.89 contract has a completion date of March 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract...
- This federal contract award, valued at $9,595.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a performance period through April 2025. The contract is a firm fixed-price arrangement and was not set aside for any special designation. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,305.16, is a Firm Fixed Price Delivery Order for the provision of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has a potential value of $1,691.17 and a performance period through February 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical supplies from its corporate office in Conshohocken, Pennsylvania. This delivery...
- This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $1,251.76 for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 30, 2024 and is a firm-fixed price arrangement. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,378.37, is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price delivery order. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9FHDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,212.72 firm fixed price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award. The contract has an ultimate completion date of April 3, 2024.
Generated 7/2/24, 3:00 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/2/24 |